WO2001075001A3 - Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide - Google Patents

Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide Download PDF

Info

Publication number
WO2001075001A3
WO2001075001A3 PCT/CN2001/000254 CN0100254W WO0175001A3 WO 2001075001 A3 WO2001075001 A3 WO 2001075001A3 CN 0100254 W CN0100254 W CN 0100254W WO 0175001 A3 WO0175001 A3 WO 0175001A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
dependant
polynucleotide encoding
protein kinase
human protein
Prior art date
Application number
PCT/CN2001/000254
Other languages
English (en)
Chinese (zh)
Other versions
WO2001075001A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Biowindow Gene Dev Inc
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biowindow Gene Dev Inc, Yumin Mao, Yi Xie filed Critical Biowindow Gene Dev Inc
Priority to AU46303/01A priority Critical patent/AU4630301A/en
Publication of WO2001075001A2 publication Critical patent/WO2001075001A2/fr
Publication of WO2001075001A3 publication Critical patent/WO2001075001A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une protéine kinase humaine dépendant de l'adénosine cyclique 9, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine kinase humaine dépendant de l'adénosine cyclique 9.
PCT/CN2001/000254 2000-03-02 2001-02-26 Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide WO2001075001A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU46303/01A AU4630301A (en) 2000-03-02 2001-02-26 A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00111864 CN1311243A (zh) 2000-03-02 2000-03-02 一种新的多肽——人cAMP依赖的蛋白激酶调节亚单位9和编码这种多肽的多核苷酸

Publications (2)

Publication Number Publication Date
WO2001075001A2 WO2001075001A2 (fr) 2001-10-11
WO2001075001A3 true WO2001075001A3 (fr) 2002-03-07

Family

ID=4581760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000254 WO2001075001A2 (fr) 2000-03-02 2001-02-26 Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide

Country Status (3)

Country Link
CN (1) CN1311243A (fr)
AU (1) AU4630301A (fr)
WO (1) WO2001075001A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446064A (en) * 1980-12-19 1984-05-01 The University Of Virginia Alumni Patents Foundation Insulin mediator substance
US5922844A (en) * 1996-06-21 1999-07-13 Incyte Pharmaceuticals, Inc. Human cAMP-dependent protein kinase inhibitor homolog

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446064A (en) * 1980-12-19 1984-05-01 The University Of Virginia Alumni Patents Foundation Insulin mediator substance
US5922844A (en) * 1996-06-21 1999-07-13 Incyte Pharmaceuticals, Inc. Human cAMP-dependent protein kinase inhibitor homolog

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 1 November 1998 (1998-11-01), BIRREN B. ET AL., Database accession no. AC005696 *
DATABASE GENBANK [online] 9 October 1999 (1999-10-09), MUZNY D. ET AL., Database accession no. AC008008 *

Also Published As

Publication number Publication date
CN1311243A (zh) 2001-09-05
AU4630301A (en) 2001-10-15
WO2001075001A2 (fr) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2001075001A3 (fr) Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075043A3 (fr) Nouveau polypeptide, proteine kinase humaine 9 adn-dependante, et polynucleotide codant pour ce polypeptide
WO2001094529A3 (fr) Nouveau polypeptide, serine hydrolase humaine atp-dependante 21, et polynucleotide codant pour ce polypeptide
WO2002000821A3 (fr) Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075048A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide
WO2001075034A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide
WO2001075035A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075057A3 (fr) Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide
WO2001083682A3 (fr) Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide
WO2001083687A3 (fr) Nouveau polypeptide, proteine pax humaine 23, et polynucleotide codant pour ce polypeptide
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2002000828A3 (fr) Nouveau polypeptide, proteine a doigt de zinc 34, et polynucleotide codant ce polypeptide
WO2001083681A3 (fr) Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide
WO2001075039A3 (fr) Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide
WO2002000823A3 (fr) Nouveau polypeptide, proteine d'activation enzymatique ras gtp 9.57, et polynucleotide codant ce polypeptide
WO2001094540A3 (fr) Nouveau polypeptide, glycosyl hydrolase humaine 23, et polynucleotide codant ce polypeptide
WO2001075028A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s4-12, et polynucleotide codant pour ce polypeptide
WO2001081536A3 (fr) Nouveau polypeptide, proteine kinase ysk1 humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075032A3 (fr) Nouveau polypeptide, glycinamide ribonucleotide synthetase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075058A3 (fr) Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide
WO2001064866A1 (fr) Nouveau polypeptide, ribosome s19e 11, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP